Blood Protein Predicts Treatment Response in Mesothelioma
A blood protein that is overexpressed in mesothelioma tumor cells may be one of the best ways to predict how well a patient will respond to treatment. is a serious malignancy of the mesothelium, or tissue that surrounds and encases the lungs, abdomen or heart. It is almost always caused by exposure to the mineral asbestos. A protein called mesothelin, which is present in all mesothelial cells, is produced in greater amounts by cancerous mesothelial cells. Scientists have long believed that this protein may be an important way to gain information about a patient’s mesothelioma cancer. A study recently published in the journal Clinical Cancer Research appears to confirm that idea. A group of Australian researchers enrolled 97 mesothelioma patients…